This is the presentation I gave at the Nosodes 2008 Conference in Cuba, December 2008.
Malaria is the world’s dominant parasitic infection. Each year 350-500 million cases of malaria occur worldwide, and over one million people die, most of them young children in sub- Saharan Africa. Malaria is the new target of the Big Pharma. They regularly advertise through the news media that within two years there will be a malaria vaccine.
Homeopaths know the meaning of this. From my field experience with suppressed malaria and quinine-type drug side-effects, I predict a rise in epileptic cases and childhood mental retardation as a result of malarial suppression through vaccination.
It is important that we are prepared for this new onslaught on the health of our populations and also that we have a homeopathic reply in prophylaxis.
Is the Allopathic Approach to Malaria Effective?
The allopathic approach over the years has been to use quinine-based and synthetic quinine drugs to control and cure the infected victim. This has led to the emergence and spread of drug resistant malaria. Now quinine has lost its place as the drug of choice in malaria treatment. As new drugs are researched, ever-stronger drug resistant malaria presents even greater challenges to world health.
The World Health Organization (WHO) has recommended replacement of mono-therapy anti- malarials by synthetic chemical derivates of Artemesia annua in combination with a quinine-based additive (ACT). We can expect that it won’t take long for drug resistance to bedevil ACT. Future treatment regimes and effective anti-malarial vaccines are, at best, still in the early stages of development.
The scientific allopathic community entirely misses the boat on the treatment of infectious diseases. The approach itself is defective. One of the major defects in the conventional approach is the futile search for the so-called “active ingredient” in any natural substance in order to isolate it, analyze it, and then chemically synthesize it in order to mass produce it. Of course this approach maximizes profit for the lucky pharmaceutical company that can produce such a product. But unfortunately, Mother Nature doesn’t work that way, and hence man-made drug- resistant bugs that are more dangerous and virulent are polluting our home ( Earth), and endangering the lives of millions of people. We humans are building our own tombs with this misguided, greed-inspired approach to medicine.
An herb or natural substance has not one, but thousands of active ingredients. It is all these natural active ingredients working together, that make whole herbs still the most effective means of treating infectious diseases, including so-called drug resistant malaria.
Some Statistics and Background of Malaria
(The following information is adapted from www.cdc.org )
Infection with malaria parasites may result in a wide variety of symptoms, ranging from absent or very mild symptoms, to severe disease and even death. Malaria disease can be categorized as uncomplicated or severe (complicated).
Following the infective bite by the Anopheles mosquito, the incubation period goes by before the first symptoms appear. The incubation period in most cases varies from 7 to 30 days. The shorter periods are observed most frequently with P. falciparum and the longer ones with P. malariae.
Anti-malarial drugs taken for prophylaxis by travelers can delay the appearance of malaria symptoms by weeks or months, long after the traveler has left the malaria-endemic area. (This can happen particularly with P. vivax and P. ovale, both of which can produce dormant liver stage parasites; the liver stages may reactivate and cause disease months after the infective mosquito bite.)
Such long delays between exposure and development of symptoms can result in misdiagnosis or delayed diagnosis, because of reduced clinical suspicion by the health-care provider. Returned travelers should always remind their health-care providers of any travel in malaria-risk areas during the past 12 months.
The classical (but rarely observed) malaria attack lasts 6-10 hours. It consists of:
â€¢ a cold stage (sensation of cold, shivering)
â€¢ a hot stage (fever, headaches, vomiting; seizures in young children)
â€¢ and finally a sweating stage (sweats, return to normal temperature, tiredness)
Classically (but infrequently observed) the attacks occur every second day with the “tertian” parasites (P. falciparum, P. vivax, and P. ovale) and every third day with the “quartan” parasite (P. malariae).
More commonly, the patient presents with a combination of the following symptoms:
â€¢ Nausea and vomiting
â€¢ Body aches
â€¢ General malaise
In countries where cases of malaria are infrequent, these symptoms may be attributed to influenza, a cold, or other common infections, especially if malaria is not suspected. Conversely, in countries where malaria is frequent, residents often recognize the symptoms as malaria and treat themselves without seeking diagnostic confirmation (“presumptive treatment”).
Physical findings may include:
â€¢ Elevated temperature
â€¢ Enlarged spleen.
In P. falciparum malaria, additional findings may include:
â€¢ Mild jaundice
â€¢ Enlargement of the liver
â€¢ Increased respiratory rate.
Diagnosis of malaria depends on the demonstration of parasites on a blood smear examined under a microscope. In P. falciparum malaria, additional laboratory findings may include mild anemia, mild decrease in blood platelets (thrombocytopenia), elevation of bilirubin, elevation of aminotransferases, albuminuria, and the presence of abnormal bodies in the urine (urinary “casts”).
Severe malaria occurs when P. falciparum infections are complicated by serious organ failures or abnormalities in the patient’s blood or metabolism. The manifestations of severe malaria include:
â€¢ Cerebral malaria, with abnormal behavior, impairment of consciousness, seizures, coma, or other neurologic abnormalities
â€¢ Severe anemia due to hemolysis (destruction of the red blood cells)
â€¢ Hemoglobinuria (hemoglobin in the urine) due to hemolysis
â€¢ Pulmonary edema (fluid buildup in the lungs) or acute respiratory distress syndrome (ARDS), which may occur even after the parasite counts have decreased in response to treatment
â€¢ Abnormalities in blood coagulation and thrombocytopenia (decrease in blood platelets)
â€¢ Cardiovascular collapse and shock
Other manifestations that should raise concern are:
â€¢ Acute kidney failure
â€¢ Hyperparasitemia, where more than 5% of the red blood cells are infected by malaria parasites
â€¢ Metabolic acidosis (excessive acidity in the blood and tissue fluids), often in association with hypoglycemia
â€¢ Hypoglycemia (low blood glucose). Hypoglycaemia may also occur in pregnant women with uncomplicated malaria, or after treatment with quinine.
Severe malaria occurs most often in persons who have no immunity to malaria or whose immunity has decreased. These include all residents of areas with low or no malaria transmission, and young children and pregnant women in areas with high transmission.
Malaria relapses or recurring malaria
In P. vivax and P. ovale infections, patients having recovered from the first episode of illness may suffer several additional attacks (“relapses”) after months or even years without symptoms. Relapses occur because P. vivax and P. ovale have dormant liver stage parasites (“hypnozoites”) that may reactivate. Treatment to reduce the chance of such relapses is available and should follow treatment of the first attack.
Other manifestations of malaria
â€¢ Neurologic defects may occasionally persist following cerebral malaria, especially in children. Such defects include troubles with movements (ataxia), palsies, speech difficulties, deafness, and blindness. (Additionally, what is not mentioned in this CDC list is epilepsy and mental retardation)
â€¢ Recurrent infections with P. falciparum may result in severe anemia. This occurs especially in young children in tropical Africa with frequent infections that are inadequately treated.
â€¢ Malaria during pregnancy (especially P. falciparum) may cause severe disease in the mother, and may lead to premature delivery or delivery of a low-birth-weight baby.
â€¢ On rare occasions, P. vivax malaria can cause rupture of the spleen or acute respiratory distress syndrome (ARDS).
â€¢ Nephrotic syndrome (a chronic, severe kidney disease) can result from chronic or repeated infections with P. malariae.
â€¢ Hyperreactive malarial splenomegaly (also called “tropical splenomegaly syndrome”) occurs infrequently and is attributed to an abnormal immune response to repeated malarial infections. The disease is marked by a very enlarged spleen and liver, abnormal immunologic findings, anemia, and a susceptibility to other infections (such as skin or respiratory infections).
Leading Causes of Death in Children Under Five Years of Age, Estimates for 2000-2003
(Source: World Health Organization, The World Health Report 2005)
Rank Cause Numbers % of all deaths
1 Neonatal causes 3,910,000 37.0%
2 Acute respiratory infections 2,027,000 19.0%
3 Diarrheal diseases 1,762,000 17.0%
4 Malaria 853,000 8.0%
5 Measles 395,000 3.0%
6 HIV/AIDS 321,000 3.0%
7 Injuries 305,000 3.0%
8 Other causes 1,022,000 10.0%
Total 10,596,000 100.0%
According to the World Health Organization’s World Malaria Report 2005:
â€¢ At the end of 2004, some 3.2 billion people lived in areas at risk of malaria transmission in 107 countries and territories.
â€¢ Between 350 and 500 million clinical episodes of malaria occur every year.
â€¢ At least one million deaths occur every year due to malaria.
â€¢ About 60% of the cases of malaria worldwide and more than 80% of the malaria deaths worldwide occur in Africa south of the Sahara.
Malaria can affect a person’s health in various ways.
â€¢ People who have developed protective immunity (through past infections, as is the case with most adults in high transmission areas) may be infected but not made ill by the parasites they carry
â€¢ In most cases, malaria causes fever, chills, headache, muscle ache, vomiting, malaise and other flu-like symptoms, which can be very incapacitating
â€¢ Some persons infected with Plasmodium falciparum can develop complications such as brain disease (cerebral malaria), severe anemia, and kidney failure. These severe forms occur more frequently in people with little protective immunity, and can result in death or life-long neurologic impairment
â€¢ People subjected to frequent malaria infections (such as young children and pregnant women in high transmission areas) can develop anemia due to frequent destruction of the red blood cells by the malaria parasites. Severely anemic patients might receive blood transfusions which, in developing countries, can expose them to HIV and other blood-borne diseases
â€¢ Babies born to women who had malaria during their pregnancy are more often born with a low birth weight or prematurely, which decreases their chances of survival during early life
â€¢ In developing countries, the harmful effects of malaria may combine with those of other highly prevalent diseases and conditions, such as malnutrition, HIV/AIDS, and anemia of all causes. Such combinations can have severe results, especially if they occur repeatedly.
Abha Light And Malaria Homeoprophylaxis
In Kenya, Abha Light Foundation has been working in the fields of malaria and HIV for 10 years, treating with homeopathy and natural medicines. After observing the ill-effects of the current treatment of malaria in dozens of patients, we developed a protocol of homeopathic medicines for all-round prophylaxis and treatment.
There are several problems that must be tackled in this wholistic protocol to malaria treatment. First of all, we must understand how the common person in a developing country deals with malaria. In this report, I am giving my practical observations only.
In Kenya, malaria is common. In the rural areas as well as in the urban slums, many people don’t have nets or use them regularly. So, they are prone to get malaria and they get it frequently. Over time, many people develop a kind of resistance to malaria, so that attacks become somewhat milder over time. But that doesn’t prevent or predict when a virulent form of P. falciparum malaria may attack anyone or if someone’s immune system is low, such as in HIV infected persons, children or malnourished from poverty.
Of course, children are most vulnerable to fatal forms of malaria. If they do survive, often they are damaged with lifelong brain disease, epilepsy, paralysis or mental retardation. The terrible burden of caring for such victims drains the mothers of hope, and drains the already impoverished family of financial resources cursing them with eternal poverty.
Malaria Treatment with Homeopathic Medicine
Before beginning this section of my presentation, I must tell you that in fact, I have done no laboratory research on this approach due to lack of funding. Homeopathy in capitalist countries is meeting great opposition simply because it challenges the pharmaceutical companies dominion over the health care of billions of people.
The research as such it is, is purely on objective, observation of cases presented analyzed homeopathically and cured. In my opinion, it is no less scientific, since the results are repeatable and consistent.
What Happens in Real Life When a Villager is Attacked with Malaria?
What happens is simple. They go to the nearest kiosk that sells sodas, biscuits and over-the- counter drugs and get some malaria medicines. Self-medication is the primary treatment, usually with out-dated therapies. Even up to August 2008, useless chloroquin-based drugs were still being sold in such kiosks. But whether it is the latest drugs or outdated ones, the patient then self-medicates and does or doesn’t get over the bout of malaria. After a week, he or she is back to work, but with lingering malaise and never quite feeling right again. This suppression mixed with side-effects produces a lingering malarial miasm, that over time weakens the immune system and produces chronic diseases in the individual.
Alternatively they may go to a nearby private community nurse or even the government hospital. There, they may or may not be properly diagnosed and, again, given drugs by injection or orally which may or may not work. But one thing is common: they will likely have lingering side- effects with each new bout of malaria and repeated rounds of malarial drugs. Relapses or re-infection is frequent with most of these cases. The conventional drugs never really clear the disease.
The third alternative is for the patient to resort to local traditional herbs. Unfortunately, in Kenya, the traditional healers have a mixed reputation and due to other factors too involved to go into here, there is little consistency in the quality of this herbal approach. It is at this stage that the patients now come in contact with us at Abha Light. What is presented to us, is a patient with a disease picture mixed with latent suppressed malaria, drug- induced side-effects and recurrent attacks.
I felt that to create an effective treatment for malaria that could be given in en masse, we had to look at all three problems and devise a wholistic solution. So let’s look at each of these problems and their solutions separately.
Recurrent or Relapsing Malaria
As written earlier: Relapses occur because P. vivax and P. ovale have dormant liver stage parasites (“hypnozoites”) that may reactivate. The challenge here is to remove the parasite from the spleen and liver in a natural way.
I will also propose that many relapses are in fact the effects of overdosing of quinine and synthetic quinine based drugs. The natural laws of homeopathic simillimum apply with all substances, whether they are intended or not.
At ALF we have chosen a locally available, but globally known herbal medicine best known as Neem. Azadirachta indica (or Melia azdirachta, Neem) is a native tree of the Indian subcontinent and has 5000 years of recorded herbal medicinal history. There is plenty of modern research done on this plant.
Neem was brought to Africa during colonial times and has readily found a home on African soil. It is found growing plentifully on the hot plains and coastal areas all over Africa. Being plentifully available in Kenya, it’s cheap and accessible to everyone. It is for this reason we choose to use Neem.
(NOTE: see article Hpathy Ezine, November, 2006 on Tara Blasco’s use of Neem in Tanzania. It was I who introduced Tara to the use of Neem)
The following information is from www.neemfoundation.org.
Practitioners of the Indian Ayurvedic medical system have been preparing neem in oral doses for malarial patients for centuries. Neem’s anti-malarial activity was reported in Ayurvedic books as far back as 2000
B.C. (by Charaka) and 1500 B.C. (by Sushruta). Even outside India-in Nigeria and Haiti, for example-neem-leaf teas are used to treat malaria.
In the past, researchers were unable to confirm that neem products can affect the malaria parasite Plasmodium falciparum. And it was not for want of trying. Various groups researching anti-malarials repeatedly tested neem. The results in infected mice, ducks, and chickens were inconsistent and usually negative.
Nonetheless, there is recent evidence that improper extraction methods may explain the earlier failures. Certain extracts of neem leaf and neem seed have now proved effective against the malarial parasite, and the structure of one active component has been determined. This compound, gedunin, is another limonoid. It is said to be as effective as quinine in malaria-infected cell cultures.
Neem leaf extract greatly increases the state of oxidation in red blood cells, which prevents normal development of the malaria virus. Irodin A, an active ingredient in the leaves, is toxic to resistant strains of malarias; 100 percent of the malaria gamete are dead within seventy-two hours with a 1 to 20,000 ratio of active ingredients. Other experiments have used alcoholic extracts of neem leaf, which performed almost as well.
Gedunin and quercetin, compounds found in the leaves, are also effective against malaria. Several studies show that neem extracts are effective even against the more virulent strains of the malaria parasite. Some scientists believe that stimulation of the immune system is a major factor in neem’s effectiveness against malaria. The plant also lowers the fever and increases one’s appetite, enabling a stronger body to fight the parasite and recover more quickly. Even though neem may be effective against the parasites that carry malaria, it has not been shown to prevent the malaria infection once it’s in the body.
At Abha Light we have harvested the neem from trees growing in rural areas in Kenya and produced our own Neem Tonic as a homeopathic 2x (or D2). It has proven its effectiveness in eliminating recurring malarias.
Patients are to take 5 drops a day for 2-3 weeks. We believe this destroys any parasites that may remain in the body and breaks the cycle of recurrent malaria. Neem 2x continues to be given successfully to thousands of Masai tribals in Tanzania. A local physician reported on it in 2006. The report is available through Abha Light’s website at www.abhalight.org